Somatropin - Growth failure - adults
You are here : Home > Formulary Search > Somatropin - Growth failure - adults
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
Evidence Review
PAD Profile
ChemicalSubstance :
Somatropin
Indication :
Growth failure - adults
Group Name :
Keywords :
shared care
Brand Names Include :
Growth hormone, Genotropin, Norditropin FlexPro, Omnitrope, Saizen, Zomacton
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Committee Recommendations (2)
16 Apr 26 -
Surrey & Sussex Area Prescribing Committee (APC)
Agreement by Chair's Action, following consultation, to change the formulary Traffic Light Status from AMBER to BLUE.
The prescribing clinical network supports Omnitrope® and Genotropin® to be presented as equal first line choices to both children and adults with other devices available as required to allow patient needs to be met.
Other Indications
Below are listed other indications that Somatropin is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Growth failure - adults.